These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29587409)

  • 1. Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux?
    Dalpiaz A; Pavan B
    Pharmaceutics; 2018 Mar; 10(2):. PubMed ID: 29587409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries.
    Dalpiaz A; Fogagnolo M; Ferraro L; Capuzzo A; Pavan B; Rassu G; Salis A; Giunchedi P; Gavini E
    Antiviral Res; 2015 Nov; 123():146-57. PubMed ID: 26427553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raltegravir permeability across blood-tissue barriers and the potential role of drug efflux transporters.
    Hoque MT; Kis O; De Rosa MF; Bendayan R
    Antimicrob Agents Chemother; 2015 May; 59(5):2572-82. PubMed ID: 25691630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.
    Zhou SF; Wang LL; Di YM; Xue CC; Duan W; Li CG; Li Y
    Curr Med Chem; 2008; 15(20):1981-2039. PubMed ID: 18691054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
    Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
    Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Systems to the Brain Obtained by Merging Prodrugs, Nanoparticles, and Nasal Administration.
    Botti G; Dalpiaz A; Pavan B
    Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of drug transporters on cellular resistance towards saquinavir and darunavir.
    König SK; Herzog M; Theile D; Zembruski N; Haefeli WE; Weiss J
    J Antimicrob Chemother; 2010 Nov; 65(11):2319-28. PubMed ID: 20817741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein.
    Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
    Eur J Pharm Sci; 2018 May; 117():35-40. PubMed ID: 29428540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ATP-binding cassette membrane transporters in rodent and human sertoli cells: relevance to the permeability of antiretroviral therapy at the blood-testis barrier.
    Robillard KR; Hoque T; Bendayan R
    J Pharmacol Exp Ther; 2012 Jan; 340(1):96-108. PubMed ID: 21990609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance in cancer or inefficacy of neuroactive agents: innovative strategies to inhibit or circumvent the active efflux transporters selectively.
    Pavan B; Paganetto G; Rossi D; Dalpiaz A
    Drug Discov Today; 2014 Oct; 19(10):1563-71. PubMed ID: 24929222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines.
    Bierman WF; Scheffer GL; Schoonderwoerd A; Jansen G; van Agtmael MA; Danner SA; Scheper RJ
    J Antimicrob Chemother; 2010 Aug; 65(8):1672-80. PubMed ID: 20551216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
    Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
    Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
    Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood-brain barrier.
    Nagasaka Y; Oda K; Iwatsubo T; Kawamura A; Usui T
    Biopharm Drug Dispos; 2012 Sep; 33(6):304-15. PubMed ID: 22847220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro.
    Cihalova D; Staud F; Ceckova M
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):105-16. PubMed ID: 25986678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells.
    Sakata S; Fujiwara M; Ohtsuka K; Kamma H; Nagane M; Sakamoto A; Fujioka Y
    Oncol Rep; 2011 Feb; 25(2):333-9. PubMed ID: 21165575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer.
    Yuan Y; Cai T; Xia X; Zhang R; Chiba P; Cai Y
    Drug Deliv; 2016 Nov; 23(9):3350-3357. PubMed ID: 27098896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.